EUVIMEDEUVIMED entdecken
Crossref

T-Cell-Derived Extracellular Vesicles with an Antitransferrin Receptor Antibody for Multicancer Targeting

Hanchae Cho iD, Hyunji Ju, Sanghee Shin, Yongdeok Ahn iD, Eunju Park, Inseong Jung, Sung-Min Kang, Soojeong Noh, Jiwon Shin iD, Jun-Kook Park, Jongwon Jeong, Daeha Seo iD und 3 weitere

Nano Letters · 2025

DOI: 10.1021/acs.nanolett.5c01830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Hanchae Cho und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Kyungpook National University School of Medicine, Daegu 41944, Republic of Korea. Hauptthemen laut MEDLINE: Extracellular Vesicles, Receptors, Transferrin, T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Daegu Gyeongbuk Institute of Science and Technology, Ministry of Science and ICT, South Korea, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent research has explored the anticancer properties of immune-cell-derived small extracellular vesicles (sEVs), but many challenges, like the need for improved targeting, remain. To address these challenges, we engineered T-cell-derived sEVs with antitransferrin receptor 1 (TfR1) antibodies (T-EVs). This modification enhanced the delivery of sEV to six types of cancer cells, as confirmed by flow cytometry, immunocytochemistry, live cell imaging, and blocking experiments in vitro. The T-EVs also reduced PD-L1 and Rab27a levels, decreased sEV production from breast cancer cells, and increased susceptibility to CD8+ T-cell-mediated cytotoxicity. Systemically administered T-EVs efficiently targeted breast, lung, and skin tumors in mouse models. Notably, T-EVs significantly inhibited tumor growth without systemic toxicity. Additionally, T-EVs reduced PD-L1 and Rab27a levels in cancer cells while enhancing the CD8+ T-cell cytotoxicity and proliferation. Overall, this study highlights the anticancer effects of T-EVs against multiple cancer types, underscoring their potential in developing targeted cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesReceptors, TransferrinT-LymphocytesAnimalsHumansMiceCell Line, TumorCD8-Positive T-LymphocytesFemaleB7-H1 Antigenrab27 GTP-Binding Proteins

Stichwörter der Autor:innen

T-cell-derived small extracellular vesiclesantibodysurface modificationtargeted therapytransferrin receptor 1

Substanzen

Receptors, TransferrinB7-H1 Antigenrab27 GTP-Binding Proteins

Autor:innen und Institutionen

  • Department of Biomedical Science, Kyungpook National University School of Medicine, Daegu 41944, Republic of Korea.
  • Department of Molecular Medicine, CMRI, Kyungpook National University School of Medicine, Daegu 41944, Republic of Korea.
  • Department of New Biology, Daegu Gyeongbuk Institute of Science & Technology, Daegu 42988, Republic of Korea.
  • Department of Physics and Chemistry, Daegu Gyeongbuk Institute of Science & Technology, Daegu 42988, Republic of Korea.
  • Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (NIH), Bethesda, Maryland 20892, Un…

ORCID-Profile: Hanchae Cho, Yongdeok Ahn, Jiwon Shin, Daeha Seo, Moon-Chang Baek

Förderung

  • Daegu Gyeongbuk Institute of Science and Technology
  • Ministry of Science and ICT, South Korea
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Cho, H., Ju, H., Shin, S., Ahn, Y., Park, E., Jung, I., Kang, S. M., Noh, S., Shin, J., Park, J. K., Jeong, J., Seo, D., Song, B. J., Yea, K., & Baek, M. C. (2025). T-Cell-Derived Extracellular Vesicles with an Antitransferrin Receptor Antibody for Multicancer Targeting. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c01830

Vancouver

Cho H, Ju H, Shin S, Ahn Y, Park E, Jung I, et al. T-Cell-Derived Extracellular Vesicles with an Antitransferrin Receptor Antibody for Multicancer Targeting. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c01830

BibTeX
@article{Cho2025,
  author = {Cho, Hanchae and Ju, Hyunji and Shin, Sanghee and Ahn, Yongdeok and Park, Eunju and Jung, Inseong and Kang, Sung-Min and Noh, Soojeong and Shin, Jiwon and Park, Jun-Kook and Jeong, Jongwon and Seo, Daeha and Song, Byoung-Joon and Yea, Kyungmoo and Baek, Moon-Chang},
  title = {T-Cell-Derived Extracellular Vesicles with an Antitransferrin Receptor Antibody for Multicancer Targeting},
  journal = {Nano Letters},
  year = {2025},
  doi = {10.1021/acs.nanolett.5c01830}
}
Kostenlos starten →